BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19666215)

  • 21. Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application.
    Leucht S
    J Clin Psychiatry; 2014; 75 Suppl 1():8-14. PubMed ID: 24581453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study.
    San L; Ciudad A; Alvarez E; Bobes J; Gilaberte I
    Eur Psychiatry; 2007 Nov; 22(8):490-8. PubMed ID: 17904337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remission in schizophrenia: results from a 1-year follow-up observational study.
    Ciudad A; Alvarez E; Bobes J; San L; Polavieja P; Gilaberte I
    Schizophr Res; 2009 Mar; 108(1-3):214-22. PubMed ID: 19168329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide Y, social function and long-term outcome in schizophrenia.
    Stålberg G; Ekselius L; Lindström LH; Larhammar D; Bodén R
    Schizophr Res; 2014 Jul; 156(2-3):223-7. PubMed ID: 24799298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
    Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of the course of illness in outpatients with schizophrenia: a prospective three year study.
    Haro JM; Novick D; Suarez D; Ochoa S; Roca M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1287-92. PubMed ID: 18502012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study.
    Amminger GP; Henry LP; Harrigan SM; Harris MG; Alvarez-Jimenez M; Herrman H; Jackson HJ; McGorry PD
    Schizophr Res; 2011 Sep; 131(1-3):112-9. PubMed ID: 21741219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of suicidal patients with schizophrenia: results from a naturalistic study.
    Schennach-Wolff R; Jäger M; Seemüller F; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ; Riedel M
    Acta Psychiatr Scand; 2010 May; 121(5):359-70. PubMed ID: 19878135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia.
    Moritz S; Veckenstedt R; Bohn F; Hottenrott B; Scheu F; Randjbar S; Aghotor J; Köther U; Woodward TS; Treszl A; Andreou C; Pfueller U; Roesch-Ely D
    Schizophr Res; 2013 Dec; 151(1-3):61-9. PubMed ID: 24183707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a functional remission threshold for the Functional Remission of General Schizophrenia (FROGS) scale.
    Boyer L; Richieri R; Guedj E; Faget-Agius C; Loundou A; Llorca PM; Auquier P; Lançon C
    Compr Psychiatry; 2013 Oct; 54(7):1016-22. PubMed ID: 23731897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interictal psychoses in comparison with schizophrenia--a prospective study.
    Tadokoro Y; Oshima T; Kanemoto K
    Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics of patients who have recovered from schizophrenia: the role of empathy and positive-self schema.
    Chung YC; Kim HM; Lee KH; Zhao T; Huang GB; Park TW; Yang JC
    Early Interv Psychiatry; 2013 May; 7(2):138-45. PubMed ID: 22765224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study.
    Haro JM; Altamura C; Corral R; Elkis H; Evans J; Krebs MO; Zink M; Malla A; Méndez JI; Bernasconi C; Lalonde J; Nordstroem AL
    Psychiatry Res; 2018 Sep; 267():56-62. PubMed ID: 29883861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The concepts of remission and recovery in schizophrenia.
    Leucht S; Lasser R
    Pharmacopsychiatry; 2006 Sep; 39(5):161-70. PubMed ID: 16944406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-based and clinician-based support for the remission criteria in schizophrenia.
    Docherty JP; Bossie CA; Lachaux B; Bouhours P; Zhu Y; Lasser R; Gharabawi GM
    Int Clin Psychopharmacol; 2007 Jan; 22(1):51-5. PubMed ID: 17159460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
    Fraguas D; Del Rey-Mejías A; Moreno C; Castro-Fornieles J; Graell M; Otero S; Gonzalez-Pinto A; Moreno D; Baeza I; Martínez-Cengotitabengoa M; Arango C; Parellada M
    Schizophr Res; 2014 Jan; 152(1):130-8. PubMed ID: 24332406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.
    Ho BC; Andreasen NC; Flaum M; Nopoulos P; Miller D
    Am J Psychiatry; 2000 May; 157(5):808-15. PubMed ID: 10784476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia.
    Lambert M; Naber D; Schacht A; Wagner T; Hundemer HP; Karow A; Huber CG; Suarez D; Haro JM; Novick D; Dittmann RW; Schimmelmann BG
    Acta Psychiatr Scand; 2008 Sep; 118(3):220-9. PubMed ID: 18699954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection.
    Lasser RA; Bossie CA; Gharabawi GM; Kane JM
    Schizophr Res; 2005 Sep; 77(2-3):215-27. PubMed ID: 15908183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.